Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07039019 · ClinicalTrials.gov registry record · Early Phase 1
Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis
A Early Phase 1 study of Pleuritis, Non-specific, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07039019 is a Early Phase 1 study of Pleuritis, Non-specific that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 40 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07039019, a Early Phase 1 study of Pleuritis, Non-specific, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This research study aims to evaluate whether corticosteroids help prevent the recurrence of pleural effusions in patients with non-specific pleuritis diagnosed through pleural biopsy. It can lead to recurrent fluid buildup in the lungs, causing discomfort and requiring additional medical interventions. There is no established treatment to prevent recurrence, and this study seeks to determine whether steroids reduce fluid buildup or cause complications. There will be two groups: one receiving corticosteroids (standard of care in the institution) and one not receiving corticosteroids (intervention group). The participation will last approximately 6 months, with in-person visits every 2 weeks for the first month, then monthly, along with possible telephone follow-ups. The study will monitor for pleural effusion recurrence, need for additional procedures, and potential side effects of corticosteroids. This is a pilot study. Although there are forty people expected to take part in this research study based on institutional data, the number of patients included in the study will be determined by the number of patients with non-specific pleuritis diagnosed during the study period.
Conditions Studied
Interventions
- DRUG Corticosteroid
- OTHER No Corticosteroid
Study Locations (2)
New York
- Mount Sinai Hospital - New York
- Mount Sinai Morningside - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2026-11-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07039019
The ClinicalTrials.gov registry entry for NCT07039019 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pleuritis, Non-specific appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid is the first listed.
NCT07039019 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07039019 about?
NCT07039019 is a clinical study titled "Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis". This research study aims to evaluate whether corticosteroids help prevent the recurrence of pleural effusions in patients with non-specific pleuritis diagnosed through pleural biopsy. It can lead to recurrent fluid buildup in the lungs, causing discomfort and requiring additional medical interventio...
What is the current status of trial NCT07039019?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2025-06-04. Estimated completion is 2026-11-19.
What conditions does trial NCT07039019 study?
This clinical trial studies the following conditions: Pleuritis, Non-specific.
What interventions are being tested in trial NCT07039019?
The interventions under investigation include: Corticosteroid (DRUG), No Corticosteroid (OTHER).
Who is sponsoring clinical trial NCT07039019?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07039019 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.